SREBF chaperone antibody (Middle Region)
Quick Overview for SREBF chaperone antibody (Middle Region) (ABIN453817)
Target
See all SREBF chaperone (SCAP) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- This antibody reacts to SCAP.
-
Purification
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human SCAP
-
-
-
-
Application Notes
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SREBF chaperone (SCAP)
-
Alternative Name
- SCAP
-
Background
- SCAP is a protein with a sterol sensing domain(SSD) and seven WD domains. In the presence of cholesterol, this protein binds to sterol regulatory element binding proteins (SREBPs) and mediates their transport from the ER to the Golgi. The SREBPs are then proteolytically cleaved and regulate sterol biosynthesis.Synonyms: KIAA0199, SREBP cleavage-activating protein, Sterol regulatory element-binding protein cleavage-activating protein
-
Gene ID
- 22937
-
NCBI Accession
- NP_036367
-
UniProt
- Q12770
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-